United States Biotechnology & Medical Research

Centessa Pharmaceuticals PLC (CNTA)

Track

Centessa Pharmaceuticals PLC experienced multiple planned and proposed sales by executives, including Karen M. Anderson and Gregory M. Weinhoff, throughout March 2026. The most recent trading activity occurred on March 26, 2026. These transactions represent divestments by key leadership personnel rather than acquisitions.
Ticker: CNTA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Centessa Pharmaceuticals PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
383.85
Quantity 3,058 -28.2%
Value US$195,250
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
212.22
Quantity 93,494 +5.0%
Value US$898,731
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
387.64
Quantity 60,490
Value US$2,131,765
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
28.15
Quantity 41,076
Value US$1,156,289
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
28.10
Quantity 10,043 -13.9%
Value US$282,210
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
27.98
Quantity 10,043
Value US$281,003
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
28.21
Quantity 64,768 -51.1%
Value US$1,826,969
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
28.21
Quantity 64,768
Value US$1,826,969
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
27.16
Quantity 11,943 -15.3%
Value US$324,336
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
26.17
Quantity 61,253 -44.0%
Value US$1,602,795
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
27.13
Quantity 12,068 -16.3%
Value US$327,439
Anderson Karen M. Chief People Officer Officer
Transaction date
Planned sale
Price
26.15
Quantity 107,961 -59.3%
Value US$2,823,234
Anderson Karen M. Officer Officer
Transaction date
Proposed sale
Price
25.86
Quantity 120,029
Value US$3,103,950
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
27.24
Quantity 73,196
Value US$1,993,493
1.5
HUSSAIN IQBAL J Chief Legal Officer Officer
Transaction date
Sale
Price
25.15
Quantity 38,951 -40.3%
Value US$979,657
1.5
HUSSAIN IQBAL J Chief Legal Officer Officer
Transaction date
Sale
Price
25.15
Quantity 38,951 -40.3%
Value US$979,657
1.5
HUSSAIN IQBAL J Chief Legal Officer Officer
Transaction date
Sale
Price
25.01
Quantity 1,010 -1.0%
Value US$25,261
1.5
Iqbal Hussain Officer Officer
Transaction date
Proposed sale
Price
25.50
Quantity 39,961
Value US$1,019,005
2.1
Saurabh Saha Former Officer Officer
Transaction date
Proposed sale
Price
22.87
Quantity 2,300,000
Value US$52,601,000
2.1
Saurabh Saha Previous Officer Officer
Transaction date
Proposed sale
Price
24.30
Quantity 2,500,000
Value US$60,750,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
29.30
Quantity 10,000
Value US$293,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
29.21
Quantity 2,568 -1.4%
Value US$75,005
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
28.70
Quantity 7,432 -3.9%
Value US$213,284
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 10,000
Value US$300,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
30.00
Quantity 10,000 -5.0%
Value US$300,000
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
28.00
Quantity 40,000 -24.8%
Value US$1,120,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
27.64
Quantity 6,000 -5.4%
Value US$165,835
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
28.00
Quantity 40,000
Value US$1,120,000
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
27.74
Quantity 6,000
Value US$166,440
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
26.00
Quantity 40,000 -24.8%
Value US$1,040,000
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
26.00
Quantity 40,000
Value US$1,040,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 8,000
Value US$200,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 8,000
Value US$200,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
25.00
Quantity 8,000 -4.0%
Value US$200,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
22.41
Quantity 6,000 -5.4%
Value US$134,439
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
22.61
Quantity 6,000
Value US$135,660
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
24.00
Quantity 35,000
Value US$840,000
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
24.00
Quantity 35,000 -22.4%
Value US$840,000
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
22.06
Quantity 8,172
Value US$180,274
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
22.02
Quantity 742 -0.4%
Value US$16,340
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
21.33
Quantity 7,430 -3.6%
Value US$158,506
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
21.81
Quantity 6,000
Value US$130,860
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
21.85
Quantity 6,000 -5.4%
Value US$131,101
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
22.00
Quantity 25,000 -17.1%
Value US$550,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
22.00
Quantity 20,000 -16.0%
Value US$440,000
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
22.00
Quantity 25,000
Value US$550,000
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
22.00
Quantity 20,000
Value US$440,000
1.6
Bush Tia L Chief Technology & Quality Ofc Officer
Transaction date
Planned sale
Price
20.00
Quantity 24,792 -16.9%
Value US$495,840
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
20.01
Quantity 20,000 -16.0%
Value US$400,102
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
20.00
Quantity 7,000 -3.3%
Value US$140,000
1.6
Bush Tia L Officer Officer
Transaction date
Proposed sale
Price
20.00
Quantity 24,792
Value US$495,840
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
20.00
Quantity 7,000
Value US$140,000
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
20.01
Quantity 20,000
Value US$400,102
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
17.23
Quantity 6,000
Value US$103,380
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
17.23
Quantity 6,000 -5.4%
Value US$103,380
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
15.37
Quantity 8,322
Value US$127,909
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
15.56
Quantity 10,000
Value US$155,598
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
15.56
Quantity 10,000 -7.6%
Value US$155,598
2.1
SAHA SAURABH Officer; CEO Officer
Transaction date
Proposed sale
Price
15.99
Quantity 55,000
Value US$879,450
2.1
SAHA SAURABH Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.92
Quantity 55,000 -19.9%
Value US$875,600
2.6
CHAO DAVID M Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 5,000
Value US$80,000
2.6
CHAO DAVID M Officer Officer
Transaction date
Proposed sale
Price
14.92
Quantity 10,000
Value US$149,182
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
14.93
Quantity 6,000 -5.4%
Value US$89,567
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
14.93
Quantity 6,000
Value US$89,567
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
13.86
Quantity 10,000 -7.6%
Value US$138,642
Accardi Mario Alberto Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 15,000
Value US$210,000
Accardi Mario Alberto President, Orexin Program Officer
Transaction date
Planned sale
Price
14.00
Quantity 15,000 -6.5%
Value US$210,000
1.5
HUSSAIN IQBAL J General Counsel Officer
Transaction date
Planned sale
Price
14.02
Quantity 12,000 -10.2%
Value US$168,218
1.5
HUSSAIN IQBAL J Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 12,000
Value US$168,218
2.6
CHAO DAVID M Officer Officer
Transaction date
Proposed sale
Price
12.87
Quantity 10,000
Value US$128,650
2.1
SAHA SAURABH Officer; CEO Officer
Transaction date
Proposed sale
Price
12.87
Quantity 55,000
Value US$707,575
2.1
SAHA SAURABH Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
12.63
Quantity 55,000 -19.9%
Value US$694,826
2.6
Weinhoff Gregory M Officer Officer
Transaction date
Proposed sale
Price
12.82
Quantity 10,000
Value US$128,225
2.6
Weinhoff Gregory M Chief Business Officer Officer
Transaction date
Planned sale
Price
12.82
Quantity 10,000 -7.6%
Value US$128,225
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-27 2026-03-26 PlS Planned sale
Anderson Karen M.

Chief People Officer

Officer
3,058 -28.2%
383.85
US$195,250 		3,058 -28.2% 383.85 US$195,250
2026-03-26 2026-03-26 PlS Planned sale
2.6
Weinhoff Gregory M

Chief Business Officer

Officer
93,494 +5.0%
212.22
US$898,731 		93,494 +5.0% 212.22 US$898,731
2026-03-26 2026-03-26 PrS Proposed sale
2.6
Weinhoff Gregory M

Officer

Officer
60,490
387.64
US$2,131,765 		60,490 387.64 US$2,131,765
2026-03-26 2026-03-26 PrS Proposed sale
Anderson Karen M.

Officer

Officer
41,076
28.15
US$1,156,289 		41,076 28.15 US$1,156,289
2026-03-18 2026-03-17 PlS Planned sale
Anderson Karen M.

Chief People Officer

Officer
10,043 -13.9%
28.10
US$282,210 		10,043 -13.9% 28.10 US$282,210
2026-03-17 2026-03-17 PrS Proposed sale
Anderson Karen M.

Officer

Officer
10,043
27.98
US$281,003 		10,043 27.98 US$281,003
2026-03-18 2026-03-16 PlS Planned sale
Anderson Karen M.

Chief People Officer

Officer
64,768 -51.1%
28.21
US$1,826,969 		64,768 -51.1% 28.21 US$1,826,969
2026-03-16 2026-03-16 PrS Proposed sale
Anderson Karen M.

Officer

Officer
64,768
28.21
US$1,826,969 		64,768 28.21 US$1,826,969
2026-03-13 2026-03-13 PlS Planned sale
2.6
Weinhoff Gregory M

Chief Business Officer

Officer
11,943 -15.3%
27.16
US$324,336 		11,943 -15.3% 27.16 US$324,336
2026-03-13 2026-03-13 PlS Planned sale
2.6
Weinhoff Gregory M

Chief Business Officer

Officer
61,253 -44.0%
26.17
US$1,602,795 		61,253 -44.0% 26.17 US$1,602,795
2026-03-13 2026-03-13 PlS Planned sale
Anderson Karen M.

Chief People Officer

Officer
12,068 -16.3%
27.13
US$327,439 		12,068 -16.3% 27.13 US$327,439
2026-03-13 2026-03-13 PlS Planned sale
Anderson Karen M.

Chief People Officer

Officer
107,961 -59.3%
26.15
US$2,823,234 		107,961 -59.3% 26.15 US$2,823,234
2026-03-13 2026-03-13 PrS Proposed sale
Anderson Karen M.

Officer

Officer
120,029
25.86
US$3,103,950 		120,029 25.86 US$3,103,950
2026-03-13 2026-03-13 PrS Proposed sale
2.6
Weinhoff Gregory M

Officer

Officer
73,196
27.24
US$1,993,493 		73,196 27.24 US$1,993,493
2026-02-03 2026-02-02 S Sale
1.5
HUSSAIN IQBAL J

Chief Legal Officer

Officer
38,951 -40.3%
25.15
US$979,657 		38,951 -40.3% 25.15 US$979,657
2026-02-03 2026-02-02 S Sale
1.5
HUSSAIN IQBAL J

Chief Legal Officer

Officer
38,951 -40.3%
25.15
US$979,657 		38,951 -40.3% 25.15 US$979,657
2026-02-03 2026-01-30 S Sale
1.5
HUSSAIN IQBAL J

Chief Legal Officer

Officer
1,010 -1.0%
25.01
US$25,261 		1,010 -1.0% 25.01 US$25,261
2026-01-30 2026-01-30 PrS Proposed sale
1.5
Iqbal Hussain

Officer

Officer
39,961
25.50
US$1,019,005 		39,961 25.50 US$1,019,005
2026-01-21 2026-01-21 PrS Proposed sale
2.1
Saurabh Saha

Former Officer

Officer
2,300,000
22.87
US$52,601,000 		2,300,000 22.87 US$52,601,000
2026-01-02 2026-01-02 PrS Proposed sale
2.1
Saurabh Saha

Previous Officer

Officer
2,500,000
24.30
US$60,750,000 		2,500,000 24.30 US$60,750,000
2025-12-09 2025-12-09 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
10,000
29.30
US$293,000 		10,000 29.30 US$293,000
2025-12-09 2025-12-09 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
2,568 -1.4%
29.21
US$75,005 		2,568 -1.4% 29.21 US$75,005
2025-12-09 2025-12-09 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
7,432 -3.9%
28.70
US$213,284 		7,432 -3.9% 28.70 US$213,284
2025-12-08 2025-12-08 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
10,000
30.00
US$300,000 		10,000 30.00 US$300,000
2025-12-08 2025-12-08 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
10,000 -5.0%
30.00
US$300,000 		10,000 -5.0% 30.00 US$300,000
2025-11-18 2025-11-17 PlS Planned sale
1.6
Bush Tia L

Chief Technology & Quality Ofc

Officer
40,000 -24.8%
28.00
US$1,120,000 		40,000 -24.8% 28.00 US$1,120,000
2025-11-18 2025-11-17 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
6,000 -5.4%
27.64
US$165,835 		6,000 -5.4% 27.64 US$165,835
2025-11-17 2025-11-17 PrS Proposed sale
1.6
Bush Tia L

Officer

Officer
40,000
28.00
US$1,120,000 		40,000 28.00 US$1,120,000
2025-11-17 2025-11-17 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
6,000
27.74
US$166,440 		6,000 27.74 US$166,440
2025-11-13 2025-11-12 PlS Planned sale
1.6
Bush Tia L

Chief Technology & Quality Ofc

Officer
40,000 -24.8%
26.00
US$1,040,000 		40,000 -24.8% 26.00 US$1,040,000
2025-11-12 2025-11-12 PrS Proposed sale
1.6
Bush Tia L

Officer

Officer
40,000
26.00
US$1,040,000 		40,000 26.00 US$1,040,000
2025-10-27 2025-10-27 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
8,000
25.00
US$200,000 		8,000 25.00 US$200,000
2025-10-27 2025-10-27 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
8,000
25.00
US$200,000 		8,000 25.00 US$200,000
2025-10-27 2025-10-27 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
8,000 -4.0%
25.00
US$200,000 		8,000 -4.0% 25.00 US$200,000
2025-10-16 2025-10-15 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
6,000 -5.4%
22.41
US$134,439 		6,000 -5.4% 22.41 US$134,439
2025-10-15 2025-10-15 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
6,000
22.61
US$135,660 		6,000 22.61 US$135,660
2025-09-24 2025-09-24 PrS Proposed sale
1.6
Bush Tia L

Officer

Officer
35,000
24.00
US$840,000 		35,000 24.00 US$840,000
2025-09-24 2025-09-24 PlS Planned sale
1.6
Bush Tia L

Chief Technology & Quality Ofc

Officer
35,000 -22.4%
24.00
US$840,000 		35,000 -22.4% 24.00 US$840,000
2025-09-16 2025-09-16 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
8,172
22.06
US$180,274 		8,172 22.06 US$180,274
2025-09-16 2025-09-16 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
742 -0.4%
22.02
US$16,340 		742 -0.4% 22.02 US$16,340
2025-09-16 2025-09-16 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
7,430 -3.6%
21.33
US$158,506 		7,430 -3.6% 21.33 US$158,506
2025-09-15 2025-09-15 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
6,000
21.81
US$130,860 		6,000 21.81 US$130,860
2025-09-15 2025-09-15 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
6,000 -5.4%
21.85
US$131,101 		6,000 -5.4% 21.85 US$131,101
2025-09-11 2025-09-10 PlS Planned sale
1.6
Bush Tia L

Chief Technology & Quality Ofc

Officer
25,000 -17.1%
22.00
US$550,000 		25,000 -17.1% 22.00 US$550,000
2025-09-11 2025-09-10 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
20,000 -16.0%
22.00
US$440,000 		20,000 -16.0% 22.00 US$440,000
2025-09-10 2025-09-10 PrS Proposed sale
1.6
Bush Tia L

Officer

Officer
25,000
22.00
US$550,000 		25,000 22.00 US$550,000
2025-09-10 2025-09-10 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
20,000
22.00
US$440,000 		20,000 22.00 US$440,000
2025-09-11 2025-09-09 PlS Planned sale
1.6
Bush Tia L

Chief Technology & Quality Ofc

Officer
24,792 -16.9%
20.00
US$495,840 		24,792 -16.9% 20.00 US$495,840
2025-09-11 2025-09-09 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
20,000 -16.0%
20.01
US$400,102 		20,000 -16.0% 20.01 US$400,102
2025-09-11 2025-09-09 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
7,000 -3.3%
20.00
US$140,000 		7,000 -3.3% 20.00 US$140,000
2025-09-09 2025-09-09 PrS Proposed sale
1.6
Bush Tia L

Officer

Officer
24,792
20.00
US$495,840 		24,792 20.00 US$495,840
2025-09-09 2025-09-09 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
7,000
20.00
US$140,000 		7,000 20.00 US$140,000
2025-09-09 2025-09-09 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
20,000
20.01
US$400,102 		20,000 20.01 US$400,102
2025-08-15 2025-08-15 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
6,000
17.23
US$103,380 		6,000 17.23 US$103,380
2025-08-15 2025-08-15 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
6,000 -5.4%
17.23
US$103,380 		6,000 -5.4% 17.23 US$103,380
2025-07-29 2025-07-29 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
8,322
15.37
US$127,909 		8,322 15.37 US$127,909
2025-07-25 2025-07-25 PrS Proposed sale
2.6
Weinhoff Gregory M

Officer

Officer
10,000
15.56
US$155,598 		10,000 15.56 US$155,598
2025-07-25 2025-07-25 PlS Planned sale
2.6
Weinhoff Gregory M

Chief Business Officer

Officer
10,000 -7.6%
15.56
US$155,598 		10,000 -7.6% 15.56 US$155,598
2025-07-21 2025-07-21 PrS Proposed sale
2.1
SAHA SAURABH

Officer; CEO

Officer
55,000
15.99
US$879,450 		55,000 15.99 US$879,450
2025-07-21 2025-07-21 PlS Planned sale
2.1
SAHA SAURABH

Chief Executive Officer

Executive Director
55,000 -19.9%
15.92
US$875,600 		55,000 -19.9% 15.92 US$875,600
2025-07-17 2025-07-17 PrS Proposed sale
2.6
CHAO DAVID M

Officer

Officer
5,000
16.00
US$80,000 		5,000 16.00 US$80,000
2025-07-17 2025-07-15 PrS Proposed sale
2.6
CHAO DAVID M

Officer

Officer
10,000
14.92
US$149,182 		10,000 14.92 US$149,182
2025-07-17 2025-07-15 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
6,000 -5.4%
14.93
US$89,567 		6,000 -5.4% 14.93 US$89,567
2025-07-15 2025-07-15 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
6,000
14.93
US$89,567 		6,000 14.93 US$89,567
2025-06-25 2025-06-25 PrS Proposed sale
2.6
Weinhoff Gregory M

Officer

Officer
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2025-06-25 2025-06-25 PlS Planned sale
2.6
Weinhoff Gregory M

Chief Business Officer

Officer
10,000 -7.6%
13.86
US$138,642 		10,000 -7.6% 13.86 US$138,642
2025-06-25 2025-06-24 PrS Proposed sale
Accardi Mario Alberto

Officer

Officer
15,000
14.00
US$210,000 		15,000 14.00 US$210,000
2025-06-25 2025-06-24 PlS Planned sale
Accardi Mario Alberto

President, Orexin Program

Officer
15,000 -6.5%
14.00
US$210,000 		15,000 -6.5% 14.00 US$210,000
2025-06-25 2025-06-24 PlS Planned sale
1.5
HUSSAIN IQBAL J

General Counsel

Officer
12,000 -10.2%
14.02
US$168,218 		12,000 -10.2% 14.02 US$168,218
2025-06-24 2025-06-24 PrS Proposed sale
1.5
HUSSAIN IQBAL J

Officer

Officer
12,000
14.02
US$168,218 		12,000 14.02 US$168,218
2025-06-20 2025-06-20 PrS Proposed sale
2.6
CHAO DAVID M

Officer

Officer
10,000
12.87
US$128,650 		10,000 12.87 US$128,650
2025-06-20 2025-06-20 PrS Proposed sale
2.1
SAHA SAURABH

Officer; CEO

Officer
55,000
12.87
US$707,575 		55,000 12.87 US$707,575
2025-06-20 2025-06-20 PlS Planned sale
2.1
SAHA SAURABH

Chief Executive Officer

Executive Director
55,000 -19.9%
12.63
US$694,826 		55,000 -19.9% 12.63 US$694,826
2025-05-27 2025-05-27 PrS Proposed sale
2.6
Weinhoff Gregory M

Officer

Officer
10,000
12.82
US$128,225 		10,000 12.82 US$128,225
2025-05-27 2025-05-27 PlS Planned sale
2.6
Weinhoff Gregory M

Chief Business Officer

Officer
10,000 -7.6%
12.82
US$128,225 		10,000 -7.6% 12.82 US$128,225
Explore more

More insider trading research around Centessa Pharmaceuticals PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America